 Home > Medical News > Medicines Company News > Kangsino Biological and other companies increase the capital of Shanghai Pharmaceutical Kangsino by about 1.1 billion yuan

Kangsino Biological and other companies increase the capital of Shanghai Pharmaceutical Kangsino by about 1.1 billion yuan

 Last Update: 2021-07-06
 Source: Internet
 Author: User

Tags

largest pharmaceutical companies

adar 2 15

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On May 17, Cansino Biopharmaceuticals issued an announcement stating that Cansino Bio and Shanghai Sanwei Biotech agreed to increase the capital of Shanghai Pharmaceutical Kangsino Biopharmaceutical Co.

Cansino Biology intends to use Shanghai Pharmaceutical Cansino as its production base in Shanghai for the production and supply of adenovirus vector new crown vaccine Keweisha.

According to the announcement, the proposed capital contribution by Cansino Biotech and Shanghai Sanwei Biotech under this capital increase is expected to be used to upgrade production facilities, hire technical and production personnel, and purchase production equipment and raw materials

Before the capital increase, Shanghai Pharmaceutical Kangsino was held by Cansino Bio, Shanghai Sanwei Biotechnology and Industrial Investment Fund respectively holding 45%, 40% and 15%; after the capital increase, Shanghai Pharmaceutical Kangsino was owned by the company, Shanghai Sanwei Biotechnology and Industrial Investment Fund.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.